Effect of influenza vaccination on the prognosis of hospitalized influenza patients

Expert Review of Vaccines

Volumn 15, Issue 3, 2016, Pages 425-432

  Casado, Itziar ^a   Domínguez, Angela ^b,c   Toledo, Diana ^c   Chamorro, Judith ^d   Force, Lluis ^e   Soldevila, Núria ^b,c   Astray, Jenaro ^f   Egurrola, Mikel ^g   Godoy, Pere ^b,h,i   Mayoral, José M ^j   Tamames, Sonia ^k   Sanz, Francisco ^l   Castilla, Jesús ^a,b  

^a IdiSNA Navarra Institute for Health Research   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Instituto de Investigación Sanitaria de Navarra   (Spain)

^e HOSPITAL DE MATARÓ   (Spain)

^f Área de Programas de Vacunación   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

^h AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

ⁱ UNIVERSITY OF LLEIDA   (Spain)

^j JUNTA DE ANDALUCÍA   (Spain)

^k Castile and León   (Spain)

^l HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

more..

Author keywords

Influenza virus; mortality; seasonal influenza vaccine; severe influenza; vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; FATALITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SEASONAL INFLUENZA; CASE CONTROL STUDY; CLINICAL TRIAL; HOSPITALIZATION; IMMUNOLOGY; INFLUENZA, HUMAN; INTENSIVE CARE; MORTALITY; MULTICENTER STUDY; PATHOLOGY; SPAIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CRITICAL CARE; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PROGNOSIS; SPAIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84959105822     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2016.1134328     Document Type: Article

References (25)

1. World Health Organization. Vaccines against influenza WHO position paper-November 2012. Wkly Epidemiol Rec. 2012; 87: 461-476.
2. Darvishian M, Bijlsma MJ, Hak E., et al. Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. Lancet Infect Dis. 2014; 14: 1228-1239.
3. Castilla J, Godoy P, Domínguez A., et al. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis. 2013; 57: 167-175.
4. McLean HQ, Meece JK, Belongia EA. Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness. Vaccine. 2014; 32: 453-457.
5. Arriola CS, Anderson EJ, Baumbach J., et al. Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012-2013 season in the United States. J Infect Dis. 2015; 212: 1200-1208.
6. Gutiérrez-Pizarraya A, Pérez-Romero P, Alvarez R., et al. Unexpected severity of cases of influenza B infections in patients that required hospitalization during the first postpandemic wave. J Infect. 2012; 65: 423-430.
7. Delgado-Rodríguez M, Castilla J, Godoy P., et al. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain. Influence of neuraminidase inhibitors. J Antimicrob Chemother. 2012; 67: 1739-1745.
8. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md Med J. 1965; 14: 61-65.
9. Ohmit SE, Petrie JG, Malosh RE., et al. Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. J Infect Dis. 2015; 211: 1519-1528.
10. McLean HQ, Thompson MG, Sundaram ME., et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis. 2014; 59: 1375-1385.
11. Chaves SS, Aragon D, Bennett N., et al. Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype. J Infect Dis. 2013; 208: 1305-1313.
12. Sistema de vigilancia de la gripe en España. Informe de Vigilancia de la Gripe en España. Temporada 2013-2014. Instituto de Salud Carlos III; 2014 [cited 2015 Sep 2]. Available from: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/Informe-GRIPE-Temporada-2013-2014-v12092014.pdf
13. Fifty-sixth World Health Assembly. Prevention and control of influenza pandemics and annual epidemics. Resolution 56.19; 2003 May 28 [cited 2015 Sep 2]. Available from: http://apps.who.int/gb/archive/pdf-files/WHA56/ea56r19.pdf
14. Jimenez-Jorge S, Pozo F, de Mateo S., et al. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveill. 2014; 19: pii:20727.
15. Jimenez-Jorge S, Pozo F, Larrauri A, The cycEVA Study Team. Interim influenza vaccine effectiveness: a good proxy for final estimates in Spain in the seasons 2010-2014. Vaccine. 2015; 33: 3276-3280.
16. VanWormer JJ, Sundaram ME, Meece JK., et al. A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting. BMC Infect Dis. 2014; 14: 231.
17. Catania J, Que LG, Govert JA., et al. High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination. Am J Resp Crit Care. 2014; 189: 485-487.
18. Perez-Romero P, Aydillo TA, Perez-Ordonez A., et al. Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease. Clin Microbiol Infect. 2012; 18: E533-40.
19. García-Gutierrez S, Quintana JM, Baricot M., et al. Predictive factors of severe multilobar pneumonia and shock in patients with influenza. Emerg Med J. 2014; 31: 301.
20. Thompson WW, Shay DK, Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289: 179-186.
21. Lang PO, Govind S, Mitchell WA., et al. Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience. Ageing Res Rev. 2011; 10: 389-395.
22. Aspinall R, Goronzy J. Immune senescence. Curr Opin Immunol. 2010; 22: 497-499.
23. Sasaki S, Sullivan M, Narvaez C., et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011; 121: 3109-3119.
24. Blomberg BB, Frasca D. Quantity, not quality, of antibody response decreased in the elderly. J Clin Invest. 2011; 121: 2981-2983.
25. Jackson LA, Nelson JC, Benson P., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol. 2006; 35: 345-352.